Rhythm Pharmaceuticals Inc

22 okt 2026, 20:07 UTC

Rhythm Pharmaceuticals Inc shares are advancing amid a significant upward movement in the Biotechnology sub-sector, gaining ground since Wednesday's close.

21 okt 2026, 19:46 UTC

Shares of Rhythm Pharmaceuticals Inc fell sharply, trading significantly below its 20-day moving average ahead of its Q3 2026 financial results announcement on November 3, 2026.

20 okt 2026, 20:13 UTC

Rhythm Pharmaceuticals Inc is trading higher in after-market hours, continuing a trend of three consecutive sessions that have also closed higher.

19 okt 2026, 20:13 UTC

Rhythm Pharmaceuticals Inc shares advanced modestly in after-market trading on Monday.

15 okt 2026, 20:07 UTC

Rhythm Pharmaceuticals receives an Overweight rating from JPMorgan, with the price target adjusted to $145.00, reflecting a continued positive outlook.

14 okt 2026, 19:56 UTC

Rhythm Pharmaceuticals Inc launched IMCIVREE in Japan as the first approved therapy for acquired hypothalamic obesity, supported by Phase 3 TRANSCEND trial data.

13 okt 2026, 22:11 UTC

Rhythm Pharmaceuticals Inc shares advanced modestly in after-market trading, correlating with slight gains in the Direxion Daily S&P Biotech Bull 3X ETF.

12 okt 2026, 19:46 UTC

Rhythm Pharmaceuticals Inc shares fell, fluctuating within a routine range and remaining significantly below its 20-day moving average.

9 okt 2026, 20:07 UTC

Rhythm Pharmaceuticals shares advanced after BofA set a new price target of $150, supported by positive feedback on its MC4R franchise for adult hypothalamic obesity.

8 okt 2026, 20:01 UTC

RBC Capital raises Rhythm Pharmaceuticals price target to $159.00 from $155.00 while maintaining an Outperform rating, citing strong market performance over five years.

7 okt 2026, 19:25 UTC

Rhythm Pharmaceuticals Inc shares fell sharply, remaining well below their 20-day moving average and significantly lower compared to Tuesday's close.

6 okt 2026, 20:30 UTC

Rhythm Pharmaceuticals Inc is experiencing a significant decline in after-market trading, moving further below its 20-day moving average since Tuesday's close.

5 okt 2026, 20:30 UTC

Rhythm Pharmaceuticals Inc is trading lower in after-market hours, continuing a trend of six consecutive daily declines and remaining below its 20-day moving average.

2 okt 2026, 20:07 UTC

Rhythm Pharmaceuticals Inc shares fell sharply, continuing a downward trend with four consecutive sessions in the red and remaining below the 20-day moving average.

1 okt 2026, 20:13 UTC

Rhythm Pharmaceuticals Inc is advancing in after-market trading, gaining ground since Thursday's close while currently trading below its 20-day moving average.

29 sep 2026, 20:07 UTC

Rhythm Pharmaceuticals Inc shares fell sharply, declining notably from Monday's close and trading well below its 20-day moving average amid ongoing pressure.

24 sep 2026, 19:25 UTC

Rhythm Pharmaceuticals Inc shares fell modestly, currently near the lower end of their one-month range and below the 20-day moving average amid broader market weakness.

23 sep 2026, 22:25 UTC

Rhythm Pharmaceuticals Inc is rising in after-market trading, recovering from an initial dip and advancing since Wednesday's close, though still below its 20-day moving average.

22 sep 2026, 20:07 UTC

Rhythm Pharmaceuticals' IMCIVREE® received Health Canada approval for weight management in patients with acquired hypothalamic obesity, boosting shares higher during the session.

21 sep 2026, 20:06 UTC

Rhythm Pharmaceuticals Inc is higher today, continuing an upward trend since Friday, despite mid-morning volatility and remaining below its 20-day moving average.

18 sep 2026, 20:06 UTC

Rhythm Pharmaceuticals Inc shares fell sharply, settling near the lower end of their one-month range and significantly below the 20-day moving average.

17 sep 2026, 20:07 UTC

Rhythm Pharmaceuticals advances during Thursday's session, boosted by a rally in the biotechnology sector following positive Phase 3 results for Moderna's cancer vaccine.

16 sep 2026, 20:10 UTC

Rhythm Pharmaceuticals Inc is experiencing an upward movement during Wednesday's trading session, recovering from an early low with a peak return of 4.17%.

15 sep 2026, 20:01 UTC

Rhythm Pharmaceuticals shares are lower amid concerns from CEO insider selling and a drop in the NY Empire State Manufacturing Index for September.

14 sep 2026, 20:08 UTC

Rhythm Pharmaceuticals Inc. shares are lower today, continuing a decline since Friday's close, despite an earlier rebound from session lows.

11 sep 2026, 19:52 UTC

Rhythm Pharmaceuticals shares are higher during Friday's session, pulling back from earlier gains. No specific news was identified to explain the movement.

8 sep 2026, 20:08 UTC

RYTM trades lower as the biotech sector faces pressure.

2 sep 2026, 20:08 UTC

Rhythm Pharmaceuticals is higher today, supported by gains in the Biotechnology sector and CFO share transactions that reflect confidence in future performance.

1 sep 2026, 19:26 UTC

Rhythm Pharmaceuticals reported a net loss of -$33.26 million on revenue of $17.28 million. Shares are lower, continuing a trend of three consecutive sessions finishing down.

31 aug 2026, 23:46 UTC

Rhythm Pharmaceuticals Inc shares rose in after-market trading, reflecting a gradual increase from earlier lows, though still below the 20-day moving average.